The Incorporation of Pharmacogenomics to Drug Development in Neuropsychiatric Disorders

Ramón Cacabelos
Additional contact information
Ramón Cacabelos: Institute of Medical Science and Genomic Medicine, EuroEspes Biomedical Research Center, Spain

Novel Approaches in Drug Designing & Development, 2017, vol. 1, issue 4, 60-63

Abstract: The global pharmaceutical sales increased from $836 billion in 2014 to $967 billion in 2016 worldwide, from $369 billion to $446 billion in the USA, and from $179 billion to $201 billion in the EU [1]. In contrast, the number of new patents for drugs [2,3] and/or FDA drug approvals per year (20-40 drugs/year) remain stagnant or in regression [4].

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555569.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555569.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:1:y:2017:i:4:p:60-63

DOI: 10.19080/NAPDD.2017.01.555569

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().